Category

Daily Briefs

Daily Brief Consumer: Toyota Motor, GHCL Textiles, Meituan, Toyota Motor Corp Spon Adr, Booking Holdings, China Education Group, MercadoLibre , Etsy Inc, Norwegian Cruise Line Holdings, Bausch + Lomb and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Last Week in Event SPACE: Toyota, Swire, Fancl, Barito Complex, Descente
  • GHCL Textile Q1 FY25 Update
  • O2O Playing a More Prominent Role in China Street Drinks
  • Toyota Motor Corporation: Investment In Future Technologies & Geographic Optimization Driving Our Optimism! – Major Drivers
  • Booking Holdings: Their Strategy Of Expansion Into Alternative Accommodations Paying Off? – Major Drivers
  • Technically Speaking, Breakouts and Breakdowns: HONG KONG (AUGUST 9)
  • MercadoLibre Inc.: Strategic Utilization of Distribution Space in Brazil & Other Major Drivers
  • Etsy Inc.: Leveraging Advanced Technologies for Enhanced User Experience! – Major Drivers
  • Norwegian Cruise Line Holdings Ltd.: These Are The 4 Major Growth Levers Driving Our ‘Buy’ Rating! – Financial Forecasts
  • Bausch + Lomb Corporation: Acquisition of Trukera Medical A Potential Game Changer? – Major Drivers


Last Week in Event SPACE: Toyota, Swire, Fancl, Barito Complex, Descente

By David Blennerhassett

  • The trade in Toyota Motor (7203 JP)‘s Tender offer Buyback is to understand what YOU can do in your particular position.
  • Despite Swire Properties (1972 HK)‘s recent share buyback, Swire Pacific (A) (19 HK) is still preferable on a look-through P/B of 0.34x.
  • Kirin bumps the Offer for Fancl (4921 JP). Given market gyration, it may represent enough of a switching opportunity to let those who still object in principle to re-allocate elsewhere. 

GHCL Textile Q1 FY25 Update

By Sudarshan Bhandari

  • Rs. 1,000 crores allocated for growth, with Rs. 350 crores deployed. 25,000 spindles added by May 2025.
  • Shift towards value-added products, including knitting, weaving, and dyed fabrics, with plans to double revenue in 3-5 years.
  • Despite expansion and potential opportunities, capacity constraints and global demand shifts temper expectations in the short term.

O2O Playing a More Prominent Role in China Street Drinks

By Andy Fu

  • On August 7th, Meituan’s on-demand order volume reached a historical high of 98mn on surging orders from street drinks. Meituan has connected to the backend systems of street drink vendors;
  • Delivery order is a double-edged sword. It boosts volume at the expense of margin. Further, the ownership of the volume is questionable;
  • With Pin-hao-fan, Meituan already atomized the small restaurants. Now Meituan is playing the same trick with street drinks. The result will be more dramatic to the benefit of Meituan.

Toyota Motor Corporation: Investment In Future Technologies & Geographic Optimization Driving Our Optimism! – Major Drivers

By Baptista Research

  • Toyota Motor Corporation has released its financial results for the fiscal year ended March 2024, providing a comprehensive overview that reflects both the company’s recent successes and its strategic investments towards future growth.
  • In fiscal year 2024, Toyota reported robust financial performance with total vehicle sales reaching 9.443 million units, marking a 7.0% increase from the previous fiscal year.
  • This growth was largely propelled by escalated sales outside Japan, counterbalancing the dip in domestic sales due to shipment suspensions from Daihatsu Motor Company and Toyota Industries Corporation.

Booking Holdings: Their Strategy Of Expansion Into Alternative Accommodations Paying Off? – Major Drivers

By Baptista Research

  • Booking Holdings, a prominent player in the global online travel market, reported its second quarter 2024 financial results, highlighting a performance that exceeded expectations in various key metrics including room nights, revenue, and adjusted EBITDA.
  • Room nights booked during the quarter grew by 7% year-over-year, achieving a total of 287 million.
  • Revenue and adjusted EBITDA both rose by 7% to $5.9 billion and $1.9 billion respectively, while adjusted earnings per share experienced an 11% increase.

Technically Speaking, Breakouts and Breakdowns: HONG KONG (AUGUST 9)

By David Mudd


MercadoLibre Inc.: Strategic Utilization of Distribution Space in Brazil & Other Major Drivers

By Baptista Research

  • MercadoLibre’s financial performance in the second quarter of 2024 highlighted robust growth and profitability, demonstrating strong execution across its primary business segments: commerce and fintech.
  • Notably, Marcos Galperin, the company’s CEO, reiterated MercadoLibre’s commitment to enhancing the financial and operational accessibility for numerous small and medium-sized enterprises across Latin America, a principle that has been foundational since the company’s inception 25 years ago.
  • From a financial perspective, the revenue reached $5.1 billion, marking a significant year-over-year growth of over 40%.

Etsy Inc.: Leveraging Advanced Technologies for Enhanced User Experience! – Major Drivers

By Baptista Research

  • Etsy, during the company’s Second Quarter 2024 Earnings, reported a Gross Merchandise Sales (GMS) of $2.9 billion, reflecting a slight year-over-year decline of 2.1% on a consolidated basis.
  • Despite the dip in GMS, revenue saw an uptick of 3%, totaling $648 million.
  • Moreover, Etsy maintained a robust adjusted EBITDA margin of approximately 28%.

Norwegian Cruise Line Holdings Ltd.: These Are The 4 Major Growth Levers Driving Our ‘Buy’ Rating! – Financial Forecasts

By Baptista Research

  • Norwegian Cruise Line Holdings recently discussed its financial performance for the second quarter of 2024, and the results have been promising, outperforming the company’s expectations and leading to upward revisions in full-year guidance.
  • President and CEO Harry Sommer along with CFO Mark Kempa provided an overview of the quarter’s milestones, emphasizing the company’s strategic balance between return on experience (ROX) and return on investment (ROI).
  • The positive outcomes from the quarter were underpinned by robust demand and strong pricing dynamics, leading to record-breaking advanced ticket sales.

Bausch + Lomb Corporation: Acquisition of Trukera Medical A Potential Game Changer? – Major Drivers

By Baptista Research

  • In the second quarter of 2024, Bausch + Lomb demonstrated notable performance across its diverse business segments and geographic regions, sustaining a trajectory of robust growth.
  • The company reported a significant year-over-year constant currency revenue growth of 20%, reflecting increases in both product volume and geographic expansion.
  • Revenue growth was consistently robust across various segments, with Surgical, Vision Care, and Pharmaceuticals growing by 9%, 11%, and 61%, respectively.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Acadia Healthcare Co, Jazz Pharmaceuticals, Regeneron Pharmaceuticals, Vertex Pharmaceuticals and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Acadia Healthcare Company: Can They Achieve Portfolio Optimization through Facility Closures? – Major Drivers
  • Jazz Pharmaceuticals plc: Expansion of Xywav in Narcolepsy and Idiopathic Hypersomnia Markets & Other Major Drivers
  • Regeneron Pharmaceuticals: A Deep Dive Into Bear’s Perspective! – Major Drivers
  • Vertex Pharmaceuticals: Advancements in Rare Disease Treatments & Overall Pipeline Development Driving Growth! – Major Drivers


Acadia Healthcare Company: Can They Achieve Portfolio Optimization through Facility Closures? – Major Drivers

By Baptista Research

  • Acadia Healthcare’s second quarter of 2024 earnings presentation illustrated a company navigating the complex terrain of the behavioral healthcare industry with notable successes as well as areas that demand attention.
  • In their earnings report, the company reported revenue of $796 million, marking an 8.8% increase over the previous year, driven by rate improvements and growth in patient days.
  • This growth is a reflection of Acadia’s ability to capture market demand, particularly in the behavioral healthcare sector, which continues to see rising need.

Jazz Pharmaceuticals plc: Expansion of Xywav in Narcolepsy and Idiopathic Hypersomnia Markets & Other Major Drivers

By Baptista Research

  • Jazz Pharmaceuticals recently reported its financial results for the second quarter of 2024, reflecting strong commercial performance and significant revenue growth across its diversified portfolio, which facilitated the company’s largest revenue quarter in its history, surpassing $1 billion.
  • In the neuroscience therapeutic area, Xywav, a key product for narcolepsy and idiopathic hypersomnia (IH), highlighted the portfolio with a significant increase of 13% in net sales compared to the same quarter the previous year.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Regeneron Pharmaceuticals: A Deep Dive Into Bear’s Perspective! – Major Drivers

By Baptista Research

  • Regeneron Pharmaceuticals reported substantial growth in its second quarter of 2024, with a 12% increase in total revenues to $3.55 billion.
  • This rise was driven significantly by the U.S. sales of EYLEA HD, which reached $304 million in its third quarter on the market.
  • The combined net product sales of EYLEA HD and EYLEA were $1.53 billion, marking a 2.3% year-over-year growth.

Vertex Pharmaceuticals: Advancements in Rare Disease Treatments & Overall Pipeline Development Driving Growth! – Major Drivers

By Baptista Research

  • Vertex Pharmaceuticals displayed robust performance in the second quarter of 2024, marked by significant progress across its various operational and developmental sectors.
  • The company’s revenue for the quarter was $2.65 billion, representing a 6% increase year-over-year.
  • Most notably, Vertex has raised its full-year product revenue guidance to between $10.65 billion and $10.85 billion, indicating a projected growth of approximately 9% compared to 2023.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Advance Create, Coinbase Global , Intercontinental Exchange and more

By | Daily Briefs, Financials

In today’s briefing:

  • Advance Create (8798 JP): Q3 FY09/24 flash update
  • Coinbase Global: These Are The 4 Biggest Factors Driving Our Bullish Thesis! – Major Drivers
  • Intercontinental Exchange: Sustaining Growth Through Strategic Acquisitions! – Major Drivers


Advance Create (8798 JP): Q3 FY09/24 flash update

By Shared Research

  • Revenue decreased JPY2.2bn YoY (-26.0% YoY) to JPY6.4bn, with significant declines in the Insurance Agency and Media businesses.
  • Operating loss decreased JPY26mn YoY to JPY610mn, with notable improvements in the Insurance Agency and Media businesses.
  • Full-year forecast revised: Revenue JPY9.5bn, Operating profit JPY200mn, Recurring profit JPY100mn, Net income JPY70mn, EPS JPY3.19.

Coinbase Global: These Are The 4 Biggest Factors Driving Our Bullish Thesis! – Major Drivers

By Baptista Research

  • Coinbase’s Q2 2024 earnings presentation revealed several vital insights into the company’s current financial health and its strategic initiatives moving forward.
  • As an investment consideration, the company disclosed robust endeavors in regulatory clarity, product development, and a diversified revenue stream along with advances in subscription and services reaching an all-time high despite a decline in transaction revenue from the previous quarter.
  • On the regulatory front, Coinbase continues to emphasize significant advancements, noting active participation in shaping cryptocurrency legislation—an undertaking likely to have profound effects on not only the company’s operations but also the broader crypto ecosystem.

Intercontinental Exchange: Sustaining Growth Through Strategic Acquisitions! – Major Drivers

By Baptista Research

  • Intercontinental Exchange demonstrated strong financial performance in the second quarter of 2024, achieving record net revenues of $2.3 billion, which is a 7% increase year-over-year on a pro forma basis.
  • Adjusted operating expenses were controlled effectively, bringing them to a total of $947 million, which is only a 1% increase from the previous year, also on a pro forma basis.
  • The company’s balance sheet showed resilience with adjusted leverage reducing from 3.9x at the end of the first quarter to 3.7x pro forma EBITDA by the end of the second quarter.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Top 10 Highlights from the APAC PE, VC and Startup Ecosystem this Week – 11 Aug 2024

By | Private Markets, Smartkarma Newswire

Top ten highlights from the APAC PE, VC, and startup ecosystem this week:

  1. Temasek Invests in GP-led Secondaries: Singapore state investor Temasek focuses on GP-led secondaries for longer asset retention.
  2. Silicon Box Secures $100M Funding: Singapore-based semiconductor startup raises funds led by Prysm Capital.
  3. Taylor’s Education Group Eyes Acquisition: Malaysian education company backed by KKR considers acquiring Vietnam-based Koala House.
  4. Macquarie Asset Management Closes South Korea PE Fund: Latest fund set to close at over 1 trillion won in Q3 of this year.

APAC Private Markets Research

Explore latest Insights on APAC Private Markets on Smartkarma


Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars

Also, check out the latest in ECM Research on Smartkarma